ATS 2026 showcased new pulmonary therapies, clinical trials, and cross-specialty collaboration to improve patient care.
Michael E. Wechsler, MD
Advertisement
Articles by Michael E. Wechsler, MD
SUNRISE data showed tezepelumab improved asthma outcomes while reducing steroid dependence in severe asthma.
SUNRISE trial data showed tezepelumab reduced oral steroid use while maintaining asthma control in severe asthma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Show MASH Progresses Faster Than Trials Suggest
2
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
3
Kazia Therapeutics Discusses Shift for Paxalisib Into Triple-Negative Breast Cancer
4
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
5